Radio and PodcastLive Radio & PodcastsScience & Medicine
110 - Kodiac Sciences FALLS on Negative Wet AMD Readout! Buying Opportunity or Falling Knife??
Kodiac Sciences is developing KSI-301 for a number of proliferative endothelial retinal disorders. Their recent P3 wet AMD data readout failed to show non-inferiority to Q8W dosed Eylea, a major upset for the company. Ho...
Related Episodes
Continue listening to more episodes from Breaking Biotech.
112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
Apr 21, 2022 - 00:43:59
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
Apr 1, 2022 - 00:28:19
109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
Feb 22, 2022 - 00:33:42
108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD
Feb 7, 2022 - 00:37:28
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
Jan 9, 2022 - 00:42:53